title: [Taurin in combined treatment of metabolic syndrome and diabetes mellitus].
abstract: In addition to information on the prevalence, etiology and pathogenesis of metabolic syndrome and type 2 diabetes mellitus, the role of insulin resistance, lipotoxicity, hyperglycemia and glucose toxicity in development complications of metabolic syndrome and diabetes mellitus, the article presents evidence from multicenter clinical trials of taurin/dibicor efficacy in the treatment of metabolic syndrome, diabetes mellitus, cardiovascular complications, diabetic retinopathy. It is demonstrated that taurin/ dibicor has a positive effect on insulin resistance and body mass in obesity, on carbohydrate and lipid metabolism, on cell membranes, blood pressure, acuity of vision. Taurin/dibicor protects against macro- and microvascular diabetic complications, improves vision, cardiovascular system condition, quality and duration of life.
mesh_terms: D015897:Comorbidity; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy* / Q000453:epidemiology; D006801:Humans; D024821:Metabolic Syndrome / Q000188:drug therapy* / Q000453:epidemiology; D015337:Multicenter Studies as Topic / Q000379:methods; D015995:Prevalence; D016032:Randomized Controlled Trials as Topic / Q000379:methods; D013654:Taurine / Q000627:therapeutic use*
chemical_list: D013654:Taurine